Real Time Genomics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

Real Time Genomics General Information

Description

Developer of genomic analysis platform deigned to reduce the cost and complexity of extracting knowledge from raw genomic data. The company's platform has deep computational expertise in algorithms, coupled with product development capabilities and a seasoned commercial team to know, anticipate and deliver to the needs of leading biological researchers, enabling physicians to get assistance in complex and childhood disease studies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Level 1, South Bloc
  • 19 Knox Street
  • Hamilton
  • New Zealand
+64 07
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Level 1, South Bloc
  • 19 Knox Street
  • Hamilton
  • New Zealand
+64 07

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Real Time Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Mar-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 08-May-2013 Completed Generating Revenue
2. Early Stage VC (Series A) $2.5M $5.5M Completed Generating Revenue
1. Early Stage VC (Series A) 15-Mar-2009 $3M $3M Completed Generating Revenue
To view Real Time Genomics’s complete valuation and funding history, request access »

Real Time Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Real Time Genomics’s complete cap table history, request access »

Real Time Genomics Patents

Real Time Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2523445-A Metagenomic analysis of samples Inactive 10-Dec-2013
GB-2506523-A A computerised assignment of genomic sequence values based on multiple reads and probabilistic analysis Inactive 31-Aug-2012
GB-201315513-D0 A method of evaluating genomic sequences Inactive 31-Aug-2012
GB-201314888-D0 A method of simultaneously evaluating multiple genomic sequences Inactive 21-Aug-2012
GB-2506274-A Bayesian analysis in evaluating biological sequences Active 21-Aug-2012 G16B30/00
To view Real Time Genomics’s complete patent history, request access »

Real Time Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Real Time Genomics FAQs

  • When was Real Time Genomics founded?

    Real Time Genomics was founded in 2009.

  • Where is Real Time Genomics headquartered?

    Real Time Genomics is headquartered in Hamilton, New Zealand.

  • What is the size of Real Time Genomics?

    Real Time Genomics has 4 total employees.

  • What industry is Real Time Genomics in?

    Real Time Genomics’s primary industry is Decision/Risk Analysis.

  • Is Real Time Genomics a private or public company?

    Real Time Genomics is a Private company.

  • What is Real Time Genomics’s current revenue?

    The current revenue for Real Time Genomics is .

  • How much funding has Real Time Genomics raised over time?

    Real Time Genomics has raised $10.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process